| Severe Acute Respiratory Syndrome Historical, Epidemiologic, and Clinical Features |
141 |
| The Middle East Respiratory Syndrome (MERS) |
71 |
| Strongyloidiasis A Neglected Tropical Disease |
23 |
| Visceral Leishmaniasis Recent Advances in Diagnostics and Treatment Regimens |
21 |
| American Trypanosomiasis (Chagas Disease) |
20 |
| Prosthetic Joint Infection Update |
17 |
| Cutaneous Leishmaniasis Updates in Diagnosis and Management |
16 |
| Understanding Biofilms and Novel Approaches to the Diagnosis, Prevention, and Treatment of Medical Device-Associated Infections |
11 |
| Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient |
11 |
| Chikungunya Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention |
11 |
| Elimination of Hepatitis C Virus in Australia Laying the Foundation |
11 |
| The Growing Threat of Antibiotic Resistance in Children |
10 |
| Urinary Catheter-Associated Infections |
9 |
| Intravascular Catheter-Related Bloodstream Infections |
9 |
| HIV and Aging Reconsidering the Approach to Management of Comorbidities |
9 |
| Norovirus Illnesses in Children and Adolescents |
9 |
| Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients |
9 |
| Ebola Virus Disease Epidemiology, Clinical Features, Management, and Prevention |
8 |
| Novel Avian Influenza A Virus Infections of Humans |
8 |
| Pediatric Community-Acquired Pneumonia in the United States Changing Epidemiology, Diagnostic and Therapeutic Challenges, and Areas for Future Research |
8 |
| Encephalitis in US Children |
8 |
| Human African Trypanosomiasis Progress and Stagnation |
8 |
| The Rickettsioses A Practical Update |
7 |
| Malaria What's New in the Management of Malaria? |
7 |
| Antibiotic-Resistant Community-Acquired Bacterial Pneumonia |
7 |
| Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice |
7 |
| Key Principles of Antiretroviral Pharmacology |
6 |
| Viral Hemorrhagic Fevers Other than Ebola and Lassa |
6 |
| Multidrug and Extensively Drug-resistant Tuberculosis Epidemiology, Clinical Features, Management and Treatment |
6 |
| Hepatitis C Virus Diagnosis and the Holy Grail |
6 |
| Vascular Graft Infections An update |
6 |
| Antimicrobial Resistance in the Tropics |
6 |
| Venomous Bites, Stings, and Poisoning: An Update |
5 |
| Cytomegalovirus Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patient |
5 |
| Lassa Fever Epidemiology, Clinical Features, Diagnosis, Management and Prevention |
5 |
| Human Monkeypox Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention |
5 |
| Viral Hepatitis Etiology, Epidemiology, Transmission, Diagnostics, Treatment, and Prevention |
5 |
| Management of Virologic Failure and HIV Drug Resistance |
4 |
| Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 000 Persons Diagnosed with Chronic Hepatitis C Virus Infection Current Chronic Hepatitis Cohort Study Status and Review of Findings |
4 |
| Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs |
4 |
| Changing Epidemiology of Haemophilus influenzae in Children |
4 |
| Breast Implant Infections An Update |
4 |
| Cardiovascular Implantable Electronic Device Infections |
4 |
| Chemotherapy and Beyond Infections in the Era of Old and New Treatments' for Hematologic Malignancies |
4 |
| Neurocysticerosis An Individualized Approach |
3 |
| Bacterial Infections in the Stem Cell Transplant Recipient and Hematologic Malignancy Patient |
3 |
| Vaccination of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient |
3 |
| Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients |
3 |
| Prevention and Treatment of Cytomegalovirus Infections in Solid Organ Transplant Recipients |
3 |
| Management of BK Polyomavirus Infection in Kidney and Kidney-Pancreas Transplant Recipients A Review Article |
3 |
